Lawrence Otto Klein, Chief Executive Officer at Oruka Therapeutics, Inc. (ORKA), sold 1,729 shares at $41.30 ($71K) on 2026-03-16, disclosed to the SEC on 2026-03-17.
Open-market sale of $71k ORKA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ORKA | SELL | 2026-09-01 | $6.9M | — | Filing → |
| ORKA | SELL | 2026-06-15 | $120K | — | Filing → |
| CRSP | SELL | 2021-03-25 | $24.1M | — | Filing → |